Overview
- CVS announced Wednesday that it will spin off its roughly 9,000 retail stores, mail pharmacy and MinuteClinic operations into a new publicly traded company called CVS Pharmacy while keeping Aetna, CVS Caremark and other health‑services businesses in a separate publicly traded company that will continue as CVS Health.
- Current CEO David Joyner will lead the health‑services company and Prem Shah will run CVS Pharmacy, the split is planned to be tax‑free for federal income tax purposes, and existing shareholders are expected to receive shares in both companies when the separation completes in the first half of 2028.
- The company unveiled the breakup alongside third‑quarter 2026 results that swung to a profit and raised full‑year guidance, but investors reacted skeptically and shares fell about 12% on the announcement.
- CVS said increasing political and state regulatory pressure over vertical integration — critics argue PBMs that negotiate drug prices can create conflicts when they also own pharmacies — was a factor in the decision, and the firms plan to keep long‑term commercial agreements between the two companies to preserve purchasing and network ties.
- The split could shift how capital and strategy are allocated, leave specialty pharmacy and high‑margin services with the health unit, and change competitive dynamics for independent pharmacies and consumers, so analysts say the key items to watch are the terms of intercompany contracts, regulatory approvals and any store‑level changes after the separation.